Fostimon 300 IU vial (refrigerator) Fostimon 300 IU Urofollitropin powder for injection – vial

264.65

Out of Stock

Product description

Product description: Fosstim used to stimulate women who do not ovulate and had no effect from treatment (Clomiphene citrate). It is used to induce the growth of more follicles (and thus more eggs) in women undergoing fertility treatment. Urofollitropin is a highly purified follicle-stimulating hormone, belonging to the group of gonadotropin drugs. Usage instructions: Always use this medicine exactly as your doctor has told you. Contact a doctor or pharmacist if you are not sure. Women who do not ovulate and have irregular or no periods: If you are in your period, treatment should start within 7 days of the start of the menstrual cycle (the first seven days of the cycle). You will receive one injection daily under the skin (subcutaneously). The usual starting dose is 75 to 150 international units of FSH Fosstim daily. This dose can be increased, if necessary, from 37.5 to 75 international units over 7 or preferably 14-day periods, to achieve the correct effect. The maximum daily dose of FSH usually does not exceed 225 international units. If your doctor does not see an effect after 4 weeks of treatment, this cycle will be stopped. For the next cycle, your doctor will prescribe a higher initial dose. When a good effect is achieved (satisfactory follicle growth), you will receive one injection of another drug (hcg) used to fully mature the follicles and release the egg. This is given 24 to 48 hours after the last Fosstim injection. You should have intercourse on the day of hcg administration and the following day. If the effect is very strong, treatment will be stopped and no hcg hormone will be given (see potential side effects). For the next cycle, your doctor will prescribe a lower initial dose. Women undergoing ovarian stimulation to develop multiple follicles before in vitro fertilization or other assisted reproductive techniques: First situation - if you are menstruating: Treatment should start after two or three days from the start of the menstrual cycle (the second or third day). You will receive one injection daily under the skin. The usual starting dose for heavy ovulation is 150 to 225 international units of Fosstim daily. Treatment continues with a dose adjusted to your response until the desired ovarian growth is achieved. This is usually achieved around the tenth day of treatment (from 5 to 20 days) and is monitored by blood tests and/or ultrasound examinations. The maximum dose is usually 450 international units per day. When the desired follicle growth is achieved, you will receive one injection of the drug used to allow full follicle maturation. This drug contains up to 10,000 international units of human chorionic gonadotropin (hcg). It will be administered 24 to 48 hours after the last Fosstim injection. Egg retrieval occurs approximately 35 hours later. Second situation - when using gonadotropin hormone (gnrh): Fosstim will be administered approximately: After two weeks from starting this treatment. Both treatments continue until the desired follicle growth is achieved. A Fosstim group will be given one injection daily, subcutaneously or intramuscularly. For example, a dose of 150 to 225 international units of Fosstim will be given in the first seven days after two weeks of stimulation, then the dose is adjusted based on ovarian response. How Fosstim should be administered: Fosstim is given by subcutaneous injection (under the skin). Each vial should be used only once, and the injection should be used immediately after preparation. If you take too much Fosstim: Contact your doctor or hospital if you have taken too much medication or if a child accidentally ingests it. For other questions about the medication, contact your doctor or pharmacist. The effects of an overdose of Fosstim are unknown, but ovarian hyperstimulation syndrome (see potential side effects) can be expected. If you forget to take Fosstim: Take it at your usual injection time. Do not double the dose to make up for the missed dose. If you stop treatment with Fosstim: Always consult your doctor if you are considering stopping treatment with this medication. Ask your doctor or pharmacist if you have any questions about using this medication. Warnings and precautions: This medication should be used under your doctor’s supervision. Do not use Fosstim if you have any of the following: Ovarian enlargement or cysts not caused by hormonal disorder (polycystic ovary syndrome). Unexplained bleeding. Ovarian, uterine, or breast cancer. Abnormal swelling (tumor) in the pituitary gland or hypothalamus (brain). Hypersensitivity (allergy) to urofollitropin or any other component of this medication. This medication should not be used if you have premature menopause or reproductive organ abnormalities or certain uterine tumors that could prevent natural pregnancy. Tell your doctor if you have: A GIC reaction to similar drugs, even if allergic reactions have not been reported with Fosstim so far. This treatment increases the risk of ovarian hyperstimulation syndrome (OHSS) (see potential side effects). In case of OHSS, treatment will be stopped and pregnancy avoided. Early signs of OHSS include lower abdominal pain, nausea, vomiting, and weight gain. If these symptoms occur, your doctor should examine you as soon as possible. In severe but rare cases, ovaries may enlarge and fluid may accumulate in the abdomen or chest. The drug used to release mature eggs (human chorionic gonadotropin - hcg) increases the risk of ovarian hyperstimulation syndrome. Therefore, the use of hcg cases where OHSS develops is not recommended, and intercourse should only be practiced at least 4 days later, even if you are using a barrier method for contraception. Please note that women with fertility problems have a higher miscarriage rate than the general population. In patients receiving ovulation induction treatment, the incidence of pregnancy and multiple births increases compared to natural conception. However, risks can be reduced by using recommended doses. There is a slight increased risk of ectopic pregnancy in women with damaged fallopian tubes. Multiple pregnancies and parental characteristics undergoing fertility treatments (such as maternal age and sperm characteristics) may be associated with an increased risk of congenital anomalies. Discuss this with your doctor before starting treatment, especially if: You already know you have an increased risk of blood clots. You or a close family member have a blood clotting disorder. You are severely obese. Other medications and Fosstim: Consult your doctor or pharmacist if you are using, have recently used, or plan to use other medications. Pregnancy and breastfeeding: Fosstim should not be used if you are pregnant or breastfeeding. Driving and machinery: Only drive or operate dangerous machinery when it is safe for you. Medications can affect your ability to drive or perform risky tasks. Components: Urofollitropin Product details: Brand: Fosstim Product model: Vial

Questions you might have

‌
‌
‌‌
‌
‌
‌‌
‌
‌
‌‌
‌
‌
‌‌
‌
‌
‌‌
‌
‌
‌‌
‌